Act Advisors, Llc. Heron Therapeutics, Inc. Transaction History
Act Advisors, Llc.
- $179 Million
- Q1 2024
A detailed history of Act Advisors, Llc. transactions in Heron Therapeutics, Inc. stock. As of the latest transaction made, Act Advisors, Llc. holds 22,145 shares of HRTX stock, worth $67,320. This represents 0.03% of its overall portfolio holdings.
Number of Shares
22,145
Previous 22,145
-0.0%
Holding current value
$67,320
Previous $37,000
64.86%
% of portfolio
0.03%
Previous 0.02%
Shares
1 transactions
Others Institutions Holding HRTX
# of Institutions
169Shares Held
119MCall Options Held
151KPut Options Held
103K-
Rubric Capital Management LP New York, NY26.7MShares$81.2 Million2.52% of portfolio
-
Orbimed Advisors LLC San Diego, CA10.1MShares$30.7 Million0.63% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.11MShares$24.7 Million0.0% of portfolio
-
Black Rock Inc. New York, NY7.29MShares$22.1 Million0.0% of portfolio
-
Velan Capital Investment Management LP Alpharetta, GA6.99MShares$21.2 Million21.7% of portfolio
About HERON THERAPEUTICS, INC.
- Ticker HRTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 118,774,000
- Market Cap $361M
- Description
- Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...